From Gene to GMP, Faster: Innovative Paths in Microbial Process Development for Non-Conjugated and Conjugated Therapies

Home | Knowledge Center | Resource Library | From Gene to GMP, Faster: Innovative Paths in Microbial Process Development for Non-Conjugated and Conjugated Therapies

Speed and scalability are redefining success in today’s microbial bioprocessing. Join us to explore proven strategies that compress development timelines and de-risk scale-up—from early discovery through GMP. Learn how innovative platforms, including PavewayPLUS™ and ShunzymeX™ streamline development processes. When paired with >30+ years of expertise in developing processes for PEGylated and conjugated biologics, FUJIFILM Biotechnologies has the unique means to support developers to rapidly enter GMP with robust, scalable, and commercially viable processes.

In this webinar, you will learn:

  • Practical ways to accelerate the path from gene to GMP without compromising quality

  • Strategies to overcome common hurdles in PEGylated and conjugated therapy development

  • How FUJIFILM Biotechnologies can support with the challenges you may not expect or understand as you scale.
Primary Interest(Required)
This field is hidden when viewing the form
Segments(Required)
This field is hidden when viewing the form
Sub-Segments(Required)
Privacy Policy(Required)
By submitting this form I agree that FUJIFILM Biotechnologies may process my data in the manner described in FUJIFILM’s Privacy Policy